(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732745 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MSH2 mRNA CTD PMID:22079256 (-)-quinic acid multiple interactions ISO RGD:732745 6480464 [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of MSH2 mRNA CTD PMID:21751221 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of MSH2 mRNA CTD PMID:32387197 1,2-dimethylhydrazine multiple interactions ISO RGD:732746 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MSH2 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:732745 6480464 Dinitrochlorobenzene binds to MSH2 protein CTD PMID:32991956 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of MSH2 mRNA CTD PMID:12655037 17beta-estradiol decreases expression ISO RGD:732745 6480464 Estradiol results in decreased expression of MSH2 mRNA CTD PMID:22082530 17beta-estradiol multiple interactions ISO RGD:732745 6480464 [Estradiol results in increased expression of MSH2 mRNA] which results in increased susceptibility to Cisplatin, [Estradiol results in increased expression of MSH2 mRNA] which results in increased susceptibility to Doxorubicin CTD PMID:28323900 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:732746 6480464 2 more ... CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732746 6480464 Tetrachlorodibenzodioxin results in increased expression of MSH2 mRNA CTD PMID:19465110 2,4-dinitrobenzenesulfonic acid decreases expression ISO RGD:732746 6480464 2, 4-dinitrobenzenesulfonic acid results in decreased expression of MSH2 mRNA CTD PMID:30116771 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of MSH2 mRNA CTD PMID:21346803 4,4'-diaminodiphenylmethane decreases expression ISO RGD:732746 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of MSH2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases methylation ISO RGD:732745 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of MSH2 gene CTD PMID:31601247 5-aza-2'-deoxycytidine decreases methylation ISO RGD:732745 6480464 Decitabine results in decreased methylation of MSH2 promoter CTD PMID:19032668 5-aza-2'-deoxycytidine multiple interactions ISO RGD:732745 6480464 Decitabine inhibits the reaction [Cadmium Chloride results in decreased expression of MSH2 mRNA], Decitabine inhibits the reaction [Cadmium Chloride results in decreased expression of MSH2 protein] CTD PMID:22112500 5-aza-2'-deoxycytidine increases expression ISO RGD:732745 6480464 Decitabine results in increased expression of MSH2 mRNA CTD PMID:19032668 , PMID:22082530 5-fluorouracil affects response to substance ISO RGD:732745 6480464 MSH2 protein affects the susceptibility to Fluorouracil CTD PMID:18949393 5-fluorouracil decreases expression ISO RGD:732745 6480464 Fluorouracil results in decreased expression of MSH2 mRNA CTD PMID:16557594 , PMID:16709241 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MSH2 mRNA CTD PMID:28959563 afimoxifene increases expression ISO RGD:732745 6480464 afimoxifene results in increased expression of MSH2 mRNA CTD PMID:16849584 aflatoxin B1 affects expression ISO RGD:732745 6480464 Aflatoxin B1 affects the expression of MSH2 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:732745 6480464 Aflatoxin B1 results in increased expression of MSH2 mRNA CTD PMID:22100608 more ... all-trans-retinoic acid decreases expression ISO RGD:732745 6480464 Tretinoin results in decreased expression of MSH2 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MSH2 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of MSH2 mRNA CTD PMID:30779732 arecoline decreases expression ISO RGD:732745 6480464 Arecoline results in decreased expression of MSH2 mRNA CTD PMID:17682004 aristolochic acid decreases expression ISO RGD:732745 6480464 aristolochic acid I results in decreased expression of MSH2 mRNA CTD PMID:33212167 arsane affects expression ISO RGD:732745 6480464 Arsenic affects the expression of MSH2 mRNA CTD PMID:17450239 arsane multiple interactions ISO RGD:732745 6480464 [Arsenic results in increased methylation of MSH2 promoter] which results in decreased expression of MSH2 mRNA CTD PMID:29499398 arsane increases methylation ISO RGD:732745 6480464 Arsenic results in increased methylation of MSH2 promoter CTD PMID:29499398 arsenic atom affects expression ISO RGD:732745 6480464 Arsenic affects the expression of MSH2 mRNA CTD PMID:17450239 arsenic atom multiple interactions ISO RGD:732745 6480464 [Arsenic results in increased methylation of MSH2 promoter] which results in decreased expression of MSH2 mRNA CTD PMID:29499398 arsenic atom increases methylation ISO RGD:732745 6480464 Arsenic results in increased methylation of MSH2 promoter CTD PMID:29499398 arsenous acid multiple interactions ISO RGD:732745 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MSH2 protein] CTD PMID:26598702 azathioprine affects response to substance ISO RGD:732746 6480464 MSH2 gene mutant form affects the susceptibility to Azathioprine CTD PMID:20923998 azathioprine decreases expression ISO RGD:732745 6480464 Azathioprine results in decreased expression of MSH2 mRNA CTD PMID:22623647 azoxystrobin increases expression ISO RGD:732745 6480464 azoxystrobin results in increased expression of MSH2 mRNA CTD PMID:33512557 benzo[a]pyrene decreases expression ISO RGD:732745 6480464 Benzo(a)pyrene results in decreased expression of MSH2 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:732745 6480464 Benzo(a)pyrene results in increased expression of MSH2 mRNA CTD PMID:32234424 , PMID:33411230 benzo[a]pyrene affects response to substance ISO RGD:732745 6480464 MSH2 protein affects the susceptibility to Benzo(a)pyrene CTD PMID:22382310 biphenyl-4-amine decreases expression ISO RGD:732745 6480464 4-biphenylamine results in decreased expression of MSH2 mRNA CTD PMID:24857880 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of MSH2 mRNA CTD PMID:26472102 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of MSH2 mRNA CTD PMID:26472102 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MSH2 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:732745 6480464 bisphenol A results in decreased methylation of MSH2 gene CTD PMID:31601247 bisphenol A affects expression ISO RGD:732745 6480464 bisphenol A affects the expression of MSH2 mRNA CTD PMID:30903817 bisphenol A affects methylation ISO RGD:732746 6480464 bisphenol A affects the methylation of MSH2 promoter CTD PMID:27334623 Butylbenzyl phthalate decreases expression EXP 6480464 butylbenzyl phthalate results in decreased expression of MSH2 mRNA CTD PMID:26472102 cadmium dichloride multiple interactions ISO RGD:732745 6480464 [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in decreased expression of MSH2 mRNA more ... CTD PMID:12634122 more ... cadmium dichloride increases expression ISO RGD:732745 6480464 Cadmium Chloride results in increased expression of MSH2 protein CTD PMID:26220685 cadmium dichloride decreases expression ISO RGD:732745 6480464 Cadmium Chloride results in decreased expression of MSH2 mRNA, Cadmium Chloride results in decreased expression of MSH2 protein CTD PMID:22112500 more ... cadmium dichloride increases methylation ISO RGD:732745 6480464 Cadmium Chloride results in increased methylation of MSH2 promoter CTD PMID:22112500 cadmium dichloride decreases expression ISO RGD:732746 6480464 Cadmium Chloride results in decreased expression of MSH2 mRNA CTD PMID:15501611 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of MSH2 promoter CTD PMID:22457795 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of MSH2 mRNA CTD PMID:12706856 carbon nanotube decreases expression ISO RGD:732746 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:31978390 carboplatin decreases expression EXP 6480464 Carboplatin results in decreased expression of MSH2 mRNA CTD PMID:18172885 carmustine affects response to substance ISO RGD:732745 6480464 MSH2 protein affects the susceptibility to Carmustine CTD PMID:18430789 chlorpromazine decreases expression ISO RGD:732745 6480464 Chlorpromazine results in decreased expression of MSH2 mRNA CTD PMID:15924885 chromium(6+) multiple interactions ISO RGD:732745 6480464 MSH2 protein promotes the reaction [Ascorbic Acid results in increased susceptibility to chromium hexavalent ion], MSH2 protein results in increased susceptibility to [chromium hexavalent ion co-treated with Ascorbic Acid] CTD PMID:17169990 , PMID:17301063 chromium(6+) increases response to substance ISO RGD:732745 6480464 MSH2 protein results in increased susceptibility to chromium hexavalent ion CTD PMID:17301063 cisplatin multiple interactions ISO RGD:732745 6480464 [Estradiol results in increased expression of MSH2 mRNA] which results in increased susceptibility to Cisplatin more ... CTD PMID:21285353 more ... cisplatin decreases expression ISO RGD:732745 6480464 Cisplatin results in decreased expression of MSH2 protein CTD PMID:21696631 cisplatin increases expression ISO RGD:732745 6480464 Cisplatin results in increased expression of MSH2 mRNA CTD PMID:27594783 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MSH2 mRNA CTD PMID:18172885 cisplatin increases response to substance ISO RGD:732746 6480464 MSH2 protein results in increased susceptibility to Cisplatin CTD PMID:21285353 cisplatin multiple interactions ISO RGD:732746 6480464 MSH2 protein promotes the reaction [Cisplatin results in increased expression of BBC3 protein] more ... CTD PMID:21285353 cisplatin affects response to substance ISO RGD:732746 6480464 MSH2 affects the susceptibility to Cisplatin, MSH2 protein affects the susceptibility to Cisplatin CTD PMID:12185594 , PMID:21667017 cisplatin increases response to substance ISO RGD:732745 6480464 MSH2 protein results in increased susceptibility to Cisplatin CTD PMID:21285353 clofibrate increases expression ISO RGD:732746 6480464 Clofibrate results in increased expression of MSH2 mRNA CTD PMID:17585979 copper atom multiple interactions ISO RGD:732745 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MSH2 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of MSH2 mRNA CTD PMID:20971185 , PMID:30911355 copper(0) multiple interactions ISO RGD:732745 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MSH2 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of MSH2 mRNA CTD PMID:20971185 , PMID:30911355 copper(II) sulfate decreases expression ISO RGD:732745 6480464 Copper Sulfate results in decreased expression of MSH2 mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:732745 6480464 Coumestrol results in increased expression of MSH2 mRNA CTD PMID:19167446 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of MSH2 mRNA CTD PMID:11056294 , PMID:11906922 cyclosporin A decreases expression ISO RGD:732745 6480464 Cyclosporine results in decreased expression of MSH2 mRNA CTD PMID:20106945 , PMID:25562108 diarsenic trioxide multiple interactions ISO RGD:732745 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MSH2 protein] CTD PMID:26598702 diazinon affects expression EXP 6480464 Diazinon affects the expression of MSH2 mRNA CTD PMID:22546817 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of MSH2 mRNA CTD PMID:21266533 , PMID:26472102 dichromium trioxide multiple interactions ISO RGD:732745 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MSH2 mRNA CTD PMID:12634122 dicrotophos decreases expression ISO RGD:732745 6480464 dicrotophos results in decreased expression of MSH2 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of MSH2 mRNA CTD PMID:22546817 Dimethyl phthalate decreases expression EXP 6480464 dimethyl phthalate results in decreased expression of MSH2 mRNA CTD PMID:26472102 dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of MSH2 mRNA CTD PMID:17481689 dioxygen decreases expression ISO RGD:732745 6480464 Oxygen deficiency results in decreased expression of MSH2 protein CTD PMID:25030372 dipentyl phthalate decreases expression EXP 6480464 di-n-pentyl phthalate results in decreased expression of MSH2 mRNA CTD PMID:26472102 dipentyl phthalate increases expression EXP 6480464 di-n-pentyl phthalate results in increased expression of MSH2 mRNA CTD PMID:26472102 doxorubicin multiple interactions ISO RGD:732745 6480464 [Estradiol results in increased expression of MSH2 mRNA] which results in increased susceptibility to Doxorubicin CTD PMID:28323900 doxorubicin decreases expression ISO RGD:732745 6480464 Doxorubicin results in decreased expression of MSH2 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO RGD:732745 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MSH2 protein CTD PMID:23301498 floxuridine multiple interactions ISO RGD:732745 6480464 olaparib inhibits the reaction [MSH2 protein results in decreased susceptibility to Floxuridine] CTD PMID:22194930 floxuridine decreases response to substance ISO RGD:732745 6480464 MSH2 protein results in decreased susceptibility to Floxuridine CTD PMID:22194930 folic acid multiple interactions ISO RGD:732746 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MSH2 mRNA CTD PMID:22206623 folic acid increases expression ISO RGD:732746 6480464 Folic Acid results in increased expression of MSH2 mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of MSH2 mRNA CTD PMID:22079235 gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of MSH2 mRNA CTD PMID:17785943 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of MSH2 mRNA CTD PMID:21782745 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MSH2 mRNA CTD PMID:22061828 glyphosate decreases expression ISO RGD:732745 6480464 glyphosate results in decreased expression of MSH2 mRNA CTD PMID:31295307 hydrogen peroxide increases expression ISO RGD:732745 6480464 [Hydrogen Peroxide results in increased expression of TP53 protein] which results in increased expression of MSH2 protein CTD PMID:15081873 hydrogen peroxide affects expression ISO RGD:732745 6480464 Hydrogen Peroxide affects the expression of MSH2 mRNA CTD PMID:26519223 hydrogen peroxide multiple interactions ISO RGD:732745 6480464 [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of MSH2 mRNA more ... CTD PMID:15081873 more ... imiquimod decreases expression ISO RGD:732746 6480464 imiquimod results in decreased expression of MSH2 mRNA CTD PMID:21878529 indirubin decreases expression ISO RGD:732745 6480464 indirubin results in decreased expression of MSH2 mRNA CTD PMID:15056799 irinotecan decreases expression ISO RGD:732745 6480464 Irinotecan metabolite results in decreased expression of MSH2 mRNA, Irinotecan results in decreased expression of MSH2 mRNA CTD PMID:15956246 irinotecan affects response to substance ISO RGD:732745 6480464 MSH2 protein affects the susceptibility to Irinotecan CTD PMID:18949393 ivermectin decreases expression ISO RGD:732745 6480464 Ivermectin results in decreased expression of MSH2 protein CTD PMID:32959892 L-ascorbic acid multiple interactions ISO RGD:732745 6480464 MSH2 protein promotes the reaction [Ascorbic Acid results in increased susceptibility to chromium hexavalent ion], MSH2 protein results in increased susceptibility to [chromium hexavalent ion co-treated with Ascorbic Acid] CTD PMID:17169990 , PMID:17301063 L-methionine decreases expression ISO RGD:732746 6480464 Methionine deficiency results in decreased expression of MSH2 mRNA, Methionine results in decreased expression of MSH2 mRNA CTD PMID:24036140 Lasiocarpine multiple interactions ISO RGD:732745 6480464 [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MSH2 mRNA CTD PMID:33884520 lead diacetate multiple interactions ISO RGD:732745 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MSH2 mRNA CTD PMID:12634122 lycopene increases expression ISO RGD:732745 6480464 lycopene results in increased expression of MSH2 mRNA CTD PMID:16886892 mechlorethamine affects response to substance ISO RGD:732746 6480464 MSH2 protein affects the susceptibility to Mechlorethamine CTD PMID:12185594 menadione affects expression ISO RGD:732745 6480464 Vitamin K 3 affects the expression of MSH2 mRNA CTD PMID:20044591 menadione multiple interactions ISO RGD:732745 6480464 MSH2 protein inhibits the reaction [POLK protein results in decreased susceptibility to Vitamin K 3] CTD PMID:31294882 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of MSH2 mRNA CTD PMID:21782745 methylarsonic acid decreases expression EXP 6480464 monomethylarsonic acid results in decreased expression of MSH2 mRNA CTD PMID:17481689 monocrotaline multiple interactions ISO RGD:732745 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of MSH2 mRNA CTD PMID:33884520 N-acetyl-L-cysteine multiple interactions ISO RGD:732745 6480464 Acetylcysteine affects the reaction [Cadmium Chloride results in decreased expression of MSH2 protein] more ... CTD PMID:28690196 , PMID:33971260 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of MSH2 gene CTD PMID:16495775 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:732745 6480464 Methylnitronitrosoguanidine results in increased expression of MSH2 mRNA CTD PMID:12634122 N-methyl-N-nitrosourea multiple interactions ISO RGD:732745 6480464 Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein], Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein] CTD PMID:16204460 N-methyl-N-nitrosourea increases response to substance ISO RGD:732746 6480464 MSH2 protein results in increased susceptibility to Methylnitrosourea CTD PMID:21285353 N-methyl-N-nitrosourea affects response to substance ISO RGD:732746 6480464 MSH2 protein affects the susceptibility to Methylnitrosourea CTD PMID:12185594 N-methyl-N-nitrosourea multiple interactions ISO RGD:732746 6480464 MSH2 protein promotes the reaction [Methylnitrosourea affects the localization of ATR protein] more ... CTD PMID:21285353 N-nitrosodiethylamine increases expression ISO RGD:732746 6480464 Diethylnitrosamine results in increased expression of MSH2 mRNA, Diethylnitrosamine results in increased expression of MSH2 protein CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:732746 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MSH2 mRNA], RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MSH2 protein] CTD PMID:17854601 nickel atom decreases expression ISO RGD:732745 6480464 Nickel results in decreased expression of MSH2 mRNA CTD PMID:23195993 olaparib multiple interactions ISO RGD:732745 6480464 olaparib inhibits the reaction [MSH2 protein results in decreased susceptibility to Floxuridine] CTD PMID:22194930 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of MSH2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MSH2 mRNA CTD PMID:25729387 ozone increases expression EXP 6480464 Ozone results in increased expression of MSH2 mRNA CTD PMID:16716893 paracetamol increases expression ISO RGD:732745 6480464 Acetaminophen results in increased expression of MSH2 mRNA CTD PMID:22230336 , PMID:33971260 paracetamol multiple interactions ISO RGD:732745 6480464 Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of MSH2 mRNA] CTD PMID:33971260 pergolide multiple interactions ISO RGD:732745 6480464 Pergolide inhibits the reaction [[Hydrogen Peroxide results in increased expression of TP53 protein] which results in increased expression of MSH2 protein] CTD PMID:15081873 phenobarbital affects expression ISO RGD:732745 6480464 Phenobarbital affects the expression of MSH2 mRNA CTD PMID:19159669 PhIP affects response to substance ISO RGD:732746 6480464 MSH2 protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine CTD PMID:11593414 PhIP affects response to substance EXP 6480464 MSH2 protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine CTD PMID:12901791 pirinixic acid multiple interactions ISO RGD:732746 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MSH2 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:732746 6480464 pirinixic acid results in increased expression of MSH2 mRNA CTD PMID:23811191 piroxicam decreases expression ISO RGD:732745 6480464 Piroxicam results in decreased expression of MSH2 mRNA CTD PMID:21858171 potassium chromate decreases expression ISO RGD:732745 6480464 potassium chromate(VI) results in decreased expression of MSH2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:732745 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MSH2 mRNA CTD PMID:22079256 pyrimidines increases response to substance ISO RGD:732745 6480464 MSH2 protein results in increased susceptibility to Pyrimidines CTD PMID:15611052 pyrimidines increases response to substance ISO RGD:732746 6480464 MSH2 protein results in increased susceptibility to Pyrimidines CTD PMID:15611052 quercetin increases expression EXP 6480464 Quercetin results in increased expression of MSH2 mRNA CTD PMID:18095365 quercetin decreases expression ISO RGD:732745 6480464 Quercetin results in decreased expression of MSH2 mRNA CTD PMID:21632981 quercetin increases expression ISO RGD:732745 6480464 Quercetin results in increased expression of MSH2 mRNA CTD PMID:14715546 resveratrol increases expression ISO RGD:732746 6480464 resveratrol results in increased expression of MSH2 protein CTD PMID:25505154 riddelliine multiple interactions ISO RGD:732745 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of MSH2 mRNA CTD PMID:33884520 silicon dioxide increases expression ISO RGD:732746 6480464 Silicon Dioxide results in increased expression of MSH2 mRNA CTD PMID:23221170 sodium arsenite multiple interactions ISO RGD:732745 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MSH2 mRNA more ... CTD PMID:12634122 more ... sodium arsenite affects expression ISO RGD:732745 6480464 sodium arsenite affects the expression of MSH2 protein CTD PMID:28690196 sodium arsenite decreases expression ISO RGD:732746 6480464 sodium arsenite results in decreased expression of MSH2 mRNA CTD PMID:25787150 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of MSH2 mRNA CTD PMID:22561333 sodium dichromate increases expression ISO RGD:732746 6480464 sodium bichromate results in increased expression of MSH2 mRNA CTD PMID:22155349 sterigmatocystin increases expression ISO RGD:732745 6480464 Sterigmatocystin results in increased expression of MSH2 mRNA, Sterigmatocystin results in increased expression of MSH2 protein CTD PMID:23296099 succimer multiple interactions ISO RGD:732746 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MSH2 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:732745 6480464 Sunitinib results in decreased expression of MSH2 mRNA CTD PMID:31533062 temozolomide decreases response to substance ISO RGD:732745 6480464 MSH2 results in decreased susceptibility to temozolomide CTD PMID:20025921 temozolomide multiple interactions ISO RGD:732746 6480464 MPG affects the reaction [MSH2 results in decreased susceptibility to temozolomide], MSH2 gene mutant form promotes the reaction [temozolomide results in increased mutagenesis of B4GALNT2] CTD PMID:20025921 temozolomide decreases response to substance ISO RGD:732746 6480464 MSH2 results in decreased susceptibility to temozolomide CTD PMID:20025921 temozolomide multiple interactions ISO RGD:732745 6480464 [temozolomide co-treated with O(6)-benzylguanine] affects the expression of MSH2 protein CTD PMID:20980775 temozolomide affects response to substance ISO RGD:732745 6480464 MSH2 protein affects the susceptibility to temozolomide CTD PMID:18430789 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MSH2 mRNA CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of MSH2 mRNA CTD PMID:34492290 tioguanine increases response to substance ISO RGD:732745 6480464 MSH2 results in increased susceptibility to Thioguanine CTD PMID:20025921 titanium dioxide decreases expression ISO RGD:732746 6480464 titanium dioxide results in decreased expression of MSH2 mRNA CTD PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MSH2 mRNA CTD PMID:25729387 triptonide decreases expression ISO RGD:732746 6480464 triptonide results in decreased expression of MSH2 mRNA CTD PMID:33045310 uranium atom affects expression ISO RGD:732745 6480464 Uranium affects the expression of MSH2 mRNA CTD PMID:15672453 urethane decreases expression ISO RGD:732745 6480464 Urethane results in decreased expression of MSH2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:732745 6480464 Valproic Acid results in decreased expression of MSH2 mRNA CTD PMID:23179753 valproic acid increases expression ISO RGD:732745 6480464 Valproic Acid results in increased expression of MSH2 mRNA CTD PMID:29154799 vorinostat decreases expression ISO RGD:732746 6480464 Vorinostat results in decreased expression of MSH2 mRNA CTD PMID:32512035 zoledronic acid decreases expression ISO RGD:732745 6480464 zoledronic acid results in decreased expression of MSH2 protein CTD PMID:17070308 zoledronic acid affects localization ISO RGD:732745 6480464 zoledronic acid affects the localization of MSH2 protein CTD PMID:17070308